1-3 of 3
Emanuela Sant'Antonio, MD
Close
Sort by
Journal Articles

Impact of Underlying Mutational Profile, and Changes during Treatment, in MPN Patients Treated with JAK Inhibitors

Paola Guglielmelli, MD PhD, Annalisa Pacilli, PhD, Giada Rotunno, MSc, Francesca Gesullo, BS, Alessandro Pancrazzi, BS, Lisa Pieri, MD PhD, Emanuela Sant'Antonio, MD, Carmela Mannarelli, MSc, Giuseppe Loscocco, Chiara Paoli, BS, Lucia Merli, BSN, Alessandro M. Vannucchi
Journal: Blood
Blood (2015) 126 (23): 353.
https://doi.org/10.1182/blood.V126.23.353.353
Published: 2015
Journal Articles

IWG-MRT 2013 Criteria-Based Assessment of Response Among 83 Patients with Myelofibrosis Treated with JAK Inhibitors: Experience of Two Centers

Lisa Pieri, MD PhD, Emanuela Sant'Antonio, MD, Elisa Rumi, MD, Paola Guglielmelli, MD PhD, Rajmonda Fjerza, MD, Chiara Paoli, BS, Lucia Merli, BSN, Mario Cazzola, MD, Alessandro M. Vannucchi
Journal: Blood
Blood (2015) 126 (23): 1615.
https://doi.org/10.1182/blood.V126.23.1615.1615
Published: 2015
Journal Articles

Whole Exome Sequencing Identifies Somatic Mutation Patterns Of Myeloid Cells In Patients With Myeloproliferative Neoplasms Treated With Allogeneic Bone Marrow Transplantation

Jelena D. Milosevic, Elisa Rumi, MD, Daniela Pietra, PhD, Klaudia Bagienski, M.Sc., Tiina Berg, Emanuela Sant'Antonio, MD, Anna Colombo, BsD, Francesco Ripamonti, MD, Mario Cazzola, MD, Robert Kralovics, PhD
Journal: Blood
Blood (2013) 122 (21): 4101.
https://doi.org/10.1182/blood.V122.21.4101.4101
Published: 2013